Biotechnology Value Fund, L.P. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Elmer who wrote (2185)	12/13/2000 7:06:54 PM
From: scaram(o)uche	Read Replies (2) of 4974

David: Are the FDA filings open to the public for review prior to the advisory board meeting? The company submissions? No. If you're talking about the FDA's review of the submission and/or questions for the panel to consider...... yes, it's a new rule. Read about it recently in (?) BioCentury, but don't remember specifics. So, how is it that the Street knows knows the data stinks and the analysts don't? You can see that I don't like the company, and that I didn't accept what they were saying as being truthful. If you've been around the sector long enough, you get to know the people. Toth is good, but he's relatively new. Mike King hired him when King was at Vector. No excuse for Berger? telling me that a lot of people knew the data was manipulated. Wouldn't surprise me at all. Even with my negative sentiment, I didn't have the guts to short into the face of their claims and data. The sector once again fails to police itself. The good companies are tainted by liars, cheats and/or incompetence (one can say, it the case of MAXM, that incompetence is in play at very least). We need a "Good Housekeeping Seal of Approval". Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next